Valuation: Viatris Inc.

Market Cap 23.44B 21.38B 19.77B 17.84B 33.6B 2,191B 34.93B 239B 94.38B 1,183B 87.96B 86.11B 3,734B P/E 2026 *
-278x
P/E 2027 * 84.4x
Enterprise Value 35.09B 32B 29.59B 26.7B 50.29B 3,279B 52.27B 357B 141B 1,770B 132B 129B 5,589B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.23x
Free-Float
90.6%
Yield 2026 *
2.47%
Yield 2027 * 2.55%
1 day-0.83%
1 week-3.70%
Current month+6.54%
1 month+8.71%
3 months+25.42%
6 months+22.91%
Current year+62.89%
1 week 20.25
Extreme 20.25
20.99
1 month 17.86
Extreme 17.86
21.2
Current year 12.19
Extreme 12.19
21.2
1 year 10.15
Extreme 10.15
21.2
3 years 6.85
Extreme 6.85
21.2
5 years 6.85
Extreme 6.85
21.2
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

2,469 0.0002%
30/09/26 Free

Director

2,117 0.0002%
15/08/26 Exercice

Chief Administrative Officer

63,631 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-3.70%+89.36%+114.60% 23.44B
-2.32%-3.79%+34.24%+133.69% 1,261B
-2.15%-2.75%+36.35%+82.05% 671B
-2.33%-3.04%+22.29%+106.80% 518B
-0.69%+0.37%+31.53%+69.78% 387B
-3.90%-6.39%+42.88%+35.41% 353B
-1.35%-0.95%+28.90%+56.34% 300B
-1.13%-1.80%+0.59%+33.00% 283B
-3.07%-5.17%+29.04%+67.26% 248B
-0.75%-0.44%+32.87%+123.96% 211B
Average -0.99%-0.21%+34.81%+82.29% 425B
Weighted average by Cap. -0.78%-0.54%+30.91%+91.70%

Financials

2026 *2027 *
Net sales 14.81B 13.51B 12.49B 11.27B 21.23B 1,384B 22.07B 151B 59.64B 747B 55.58B 54.41B 2,360B 15.33B 13.98B 12.92B 11.66B 21.97B 1,432B 22.83B 156B 61.7B 773B 57.5B 56.3B 2,441B
Net income -115M -104M -96.56M -87.14M -164M -10.7B -171M -1.17B -461M -5.78B -430M -421M -18.24B 339M 309M 286M 258M 486M 31.7B 505M 3.46B 1.37B 17.11B 1.27B 1.25B 54.03B
Net Debt 11.64B 10.62B 9.82B 8.86B 16.69B 1,088B 17.35B 119B 46.88B 587B 43.69B 42.77B 1,855B 10.74B 9.8B 9.06B 8.17B 15.4B 1,004B 16B 109B 43.24B 542B 40.3B 39.46B 1,711B
Projected Income Statement - Annual - Viatris Inc.
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
18/11/26 $20.28 -0.83% 13,110,376
17/11/26 $20.45 -1.40% 10,384,303
16/11/26 $20.74 -0.38% 15,678,651
13/11/26 $20.82 +0.73% 6,514,717
12/11/26 $20.67 -1.85% 8,788,386
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Viatris Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
20.45USD
Average target price
21.60USD
Spread / Average Target
+5.62%
  1. Stock Market
  2. Stocks
  3. VTRS Stock